Edwards Lifesciences Corporation EW NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score

74/100

6/7 Pass

SharesGrow Intrinsic Value

Edwards Lifesciences Corporation (EW) 报告总资产为 $13.7B 总负债为 $3.36B 財年 2025, 总权益为 $10.34B.

公司持有 $4.23B 现金及短期投资. 总债务为 $705.4M, 净债务为 $-2.23B. D/E比率为 0.07 (保守的).

流动比率为 3.72, 表明短期流动性强.

本页支持的标准:

HEALTH (100/100, Pass) — Debt-to-Equity of 0.07, current ratio of 3.72 — 资产负债表强劲
MOAT (76/100) — 总资产 $13.7B 和 equity $10.34B 支持公司的竞争规模
VALUE (32/100) — Debt-to-Equity 0.07 影响整体估值风险评估

SharesGrow 收入评分: 74/100 其中 6/7 项标准通过.

SharesGrow 7-Criteria Score

74/100

SG Score

View full scorecard →

✗

价值

32/100

Price-to-Earnings & upside

→ Valuation

✓

未來

67/100

Analyst consensus

→ Forecast

✓

过去

100/100

→ Income

✓

健康

100/100

Debt-to-Equity & liquidity

Proven by this page

✓

护城河

76/100

→ Income

✓

成长

73/100

→ Income

✓

收入

70/100

→ Income

Edwards Lifesciences Corporation 资产负债表历史

指标	FY2025	FY2024	FY2023	FY2022
总资产	$13.7B	$13.06B	$9.36B	$8.29B
Total Liabilities	$3.36B	$2.99B	$2.64B	$2.49B
总债务	$705.4M	$700M	$694.9M	$691.3M
Cash & Investments	$4.23B	$3.98B	$1.64B	$1.22B
股东权益总计	$10.34B	$10B	$6.65B	$5.81B